Related Experiment Video
Updated: Sep 25, 2025
07:43
Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
2.5K
Regulatory strategies for early device development and approval
David R Holmes1, Rick Geoffrion2, Jon Hunt3
1Mayo Clinic, Rochester, Minnesota, USA.
Summary
Developing new cardiovascular disease technology requires careful planning. This article outlines key early steps for efficient innovation involving physicians, regulators, and industry to meet clinical needs.
Area of Science:
- Cardiovascular disease research and innovation
- Medical device development
- Regulatory science
Background:
- Modern cardiovascular disease treatment relies on technological advancements.
- Recent regulatory guidance (FDA, 21st Century Cures Act) highlights the need for innovation.
- Stakeholders include physician innovators, scientists, professional societies, regulatory bodies, and device companies.
Purpose of the Study:
- To outline the critical early-stage steps for optimizing medical device innovation in cardiovascular disease.
- To facilitate timely and efficient development of new technologies addressing unmet clinical needs.
Main Methods:
- Focus on the iterative process of early-stage device development.
- Analysis of stakeholder roles and interactions.
- Consideration of regulatory pathways and requirements.
Main Results:
- Identified key early iterative steps crucial for successful device development.
- Highlighted the importance of collaboration among diverse stakeholders.
- Emphasized the need for a structured approach to innovation.
Conclusions:
- Optimizing early-stage processes is essential for efficient cardiovascular device innovation.
- Effective collaboration and adherence to regulatory guidance accelerate the development of new technologies.
- Addressing unmet clinical needs in cardiovascular disease requires a strategic approach to innovation.
Related Concept Videos
01:25Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:28Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
01:26Drug Administration and Therapy Phases: Overview
804
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
804
01:03Drug Control Governance: Regulatory Bodies and Their Impact
265
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
265
01:28Global Regulatory Systems
95
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
95